Eswatini HIV/AIDS Adult Prevalence Rate 2024: 23.40 %
Eswatini's hiv/aids adult prevalence rate in 2024 is 23.40 %, down 3.7% from 2023. It ranks #1 of 148 countries.
HIV/AIDS Adult Prevalence Rate reveals the percentage of adults affected. Compare countries, explore rankings, and view historical trends.
Source (2024): Prevalence of HIV, total (% of population ages 15-49), World Bank (WB)
Where Eswatini ranks (2024)
#1 of 148
HIV/AIDS Adult Prevalence Rate over time
| Year | Value | Change | % Change | Actions |
|---|---|---|---|---|
| 2024 | 23.4 % | 0.9 % | -3.70% | |
| 2023 | 24.3 % | 0.9 % | -3.57% | |
| 2022 | 25.2 % | 0.9 % | -3.45% | |
| 2021 | 26.1 % | 0.8 % | -2.97% | |
| 2020 | 26.9 % | 0.7 % | -2.54% | |
| 2019 | 27.6 % | 0.5 % | -1.78% | |
| 2018 | 28.1 % | 0.5 % | -1.75% | |
| 2017 | 28.6 % | 0.4 % | -1.38% | |
| 2016 | 29 % | 0.3 % | -1.02% | |
| 2015 | 29.3 % | 0.1 % | -0.34% | |
| 2014 | 29.4 % | +0.2 % | +0.68% | |
| 2013 | 29.2 % | +0.4 % | +1.39% | |
| 2012 | 28.8 % | +0.4 % | +1.41% | |
| 2011 | 28.4 % | +0.4 % | +1.43% | |
| 2010 | 28 % | +0.3 % | +1.08% | |
| 2009 | 27.7 % | +0.2 % | +0.73% | |
| 2008 | 27.5 % | +0.3 % | +1.10% | |
| 2007 | 27.2 % | +0.2 % | +0.74% | |
| 2006 | 27 % | +0.2 % | +0.75% | |
| 2005 | 26.8 % | +0.2 % | +0.75% | |
| 2004 | 26.6 % | +0.3 % | +1.14% | |
| 2003 | 26.3 % | +0.4 % | +1.54% | |
| 2002 | 25.9 % | +0.7 % | +2.78% | |
| 2001 | 25.2 % | +1 % | +4.13% | |
| 2000 | 24.2 % | +1.4 % | +6.14% | |
| 1999 | 22.8 % | +1.8 % | +8.57% | |
| 1998 | 21 % | +2.4 % | +12.90% | |
| 1997 | 18.6 % | +2.8 % | +17.72% | |
| 1996 | 15.8 % | +3.2 % | +25.40% | |
| 1995 | 12.6 % | +3.3 % | +35.48% | |
| 1994 | 9.3 % | +2.8 % | +43.08% | |
| 1993 | 6.5 % | +2.4 % | +58.54% | |
| 1992 | 4.1 % | +1.8 % | +78.26% | |
| 1991 | 2.3 % | +1.1 % | +91.67% | |
| 1990 | 1.2 % | — | — |
Cite this page
Geo Factbook. (n.d.). Eswatini: HIV/AIDS Adult Prevalence Rate. Retrieved November 13, 2026, from https://geofactbook.com/countries/eswatini/hivaids-adult-prevalence-rate
The figures on this page come from Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank. For academic work, cite the original source as well.
Frequently Asked Questions About Eswatini HIV/AIDS Adult Prevalence Rate
What is Eswatini's hiv/aids adult prevalence rate in 2024?▾
Eswatini's hiv/aids adult prevalence rate is 23.40 % in 2024, according to Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank.
Is Eswatini's hiv/aids adult prevalence rate increasing or decreasing?▾
Eswatini's hiv/aids adult prevalence rate fell by 3.7% from 2023 (24.30 %) to 2024 (23.40 %). Over the past decade (2014–2024) it fell by 20.4%.
How does Eswatini rank for hiv/aids adult prevalence rate?▾
In 2024, Eswatini has the 1st highest hiv/aids adult prevalence rate out of 148 countries with data.
What was Eswatini's hiv/aids adult prevalence rate in 1990?▾
In 1990, Eswatini's hiv/aids adult prevalence rate was 1.20 %. By 2024 it rose by 1850.0%.
Explore additional statistical insights
Total Number of Doctors in Eswatini
The total number of doctors in each country reflects healthcare workforce size and capacity to serve the population.
Nurses and Midwives Density in Eswatini
Nurses and midwives density measures healthcare accessibility. Learn about countries with the highest and lowest density per 1,000 people.
Highest Male Life Expectancy in Eswatini
Discover countries where males live the longest, with life expectancy surpassing global averages significantly.
Mean Age at First Birth in Eswatini
Mean age at first birth indicates maternal age trends. Compare countries, explore rankings, and see historical shifts with interactive maps.
Health Coverage Index Score in Eswatini
Health Coverage Index Score assesses a country's capacity to provide essential health services to its population.
Pharmacists Density in Eswatini
Pharmacists density indicates healthcare accessibility; a higher number suggests better pharmaceutical services per 10,000 people.